T2D
Clinical trials for T2D explained in plain language.
Never miss a new study
Get alerted when new T2D trials appear
Sign up with your email to follow new studies for T2D, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes drug protect kidneys in obesity? new trial investigates
Disease control CompletedThis Phase 2 trial tests whether tirzepatide, a drug already used for diabetes and weight loss, can improve kidney health in 140 people with obesity and chronic kidney disease (with or without type 2 diabetes). Researchers will use MRI scans to measure changes in kidney fat and b…
Matched conditions: T2D
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can a fitbit and AI texts get sedentary diabetes patients moving?
Disease control CompletedThis study is testing whether giving people with type 2 diabetes a Fitbit and sending them personalized text messages from an AI chatbot can help them become more active and improve their health. Thirty-six sedentary adults will wear the Fitbit daily for 12 weeks and receive week…
Matched conditions: T2D
Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New diabetes drug shows promise for teens in landmark trial
Disease control CompletedThis study tested a medication called tirzepatide in children and teenagers aged 10 to 17 with type 2 diabetes. Participants were already taking metformin or insulin but still had high blood sugar. The goal was to see if tirzepatide could safely lower blood sugar levels better th…
Matched conditions: T2D
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC